Crossmark

Development of a clinical prediction model for sensitivity to combination therapy of Bcl-2 inhibitors and hypomethylating agents in elderly/unfit patients with acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1007/s12672-025-02612-1

Published Online: 2025-05-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Du, Yufeng

Li, Chunhong

Chen, Yonghong

Xie, Fang

Yan, Jinsong
Funding

Funding for this research was provided by:

Science and Technology Innovation Foundation of Dalian (2024JJ13PT069, 2024JJ13PT069)
License Information

Text and Data Mining valid from 2025-05-20

Version of Record valid from 2025-05-20
More Information

Article History

Received: 3 February 2025

Accepted: 7 May 2025

First Online: 20 May 2025

Declarations

:

: The authors declare no competing interests.

: Written informed consent was obtained from the patient for the publication of this paper.

: This study was approved for implementation by the Ethics Committee of the Second Affiliated Hospital of Dalian Medical University (Lot Number: KY2024-183-01).

Document is current

Any future updates will be listed below